Genomic Variant Assurance
A bounded variant-review gate for genomics programs — combining variant burden, pathogenicity signal, evolutionary conservation and epigenetic context into one verdict, with a built-in human-review checkpoint before a call moves into a report.
Who this is for
Clinical genomics and diagnostic labs
Teams reviewing variant calls before they go into a clinical report and need a consistent, defensible gate every case passes through.
Genetic counselors and clinical geneticists
Teams that need an ACMG-aligned pathogenicity read alongside a clear signal for when a case must go to human review.
Population and evolutionary genomics researchers
Teams assessing variant significance across cohorts using conservation and evolutionary-pressure signals, not just a single pathogenicity flag.
Program and QA leads
Teams that need every variant reviewed against the same standard, regardless of which analyst or lab produced the original call.
The problem you already have
A strong pathogenicity flag can conflict with conservation context
A variant may look concerning in one scoring layer while evolutionary conservation points to a less clear interpretation. The useful gate is not to erase that disagreement, but to preserve it as an explicit review condition before the case advances.
Epigenetic context can change how a variant-level signal should be read
Part 59 extends genomic review into regulatory-network context, including chromatin accessibility and enhancer-promoter relationships. For S06, that supports a conservative rule: epigenetic context should remain visible beside pathogenicity and conservation evidence rather than being treated as an afterthought.
Clinical-facing workflow still requires a human gate
The patent lineage remains research-only and the page itself does not ingest raw sequencing or patient-identifying data. S06 therefore produces a bounded evidence record and human-review flag; it does not issue a diagnosis or autonomously release a variant call into a clinical report.
Real-World Operational Scenario: The Pathogenic-Looking Variant With Conflicting Conservation and Epigenetic Context
Scenario: A case carries a strong pathogenicity signal, but conservation and regulatory context do not point in the same direction.
A genomics review team is deciding whether the call can move forward or must be escalated. The headline pathogenicity evidence is strong enough to attract attention, but the supporting evolutionary and epigenetic summary is mixed.
WITHOUT this gate: The strongest pathogenicity flag can dominate the case review, while conservation or epigenetic disagreement survives only in analyst notes and may be inconsistently escalated.
WITH this gate: Variant burden, pathogenicity, conservation and epigenetic context remain part of one bounded evidence record. The contradiction stays visible, the human-review requirement is explicit, and the program retains a timestamped record of why the case did or did not advance.
What BivectorAI Provides
Variant Evidence Consistency Gate
Reviews the supplied variant-summary evidence as one bounded record so pathogenicity, burden, conservation and epigenetic context can be compared without silently discarding conflicts.
Conservation and Evolutionary-Pressure Context
Preserves whether evolutionary evidence supports, weakens or leaves unresolved the supplied pathogenicity signal instead of treating conservation as a secondary annotation.
Regulatory-Context Awareness
Uses only the supplied epigenetic summary to preserve regulatory-context evidence relevant to the case, without requiring raw genomic-coordinate files or claiming full regulatory-network reconstruction.
Human-Review and Evidence Boundary
Returns an explicit review gate and tamper-evident case record while leaving diagnosis, report release and final clinical interpretation with qualified human reviewers.
Prove the Gate Before Broader Integration
Back-test S06 against a frozen historical case set before embedding it deeper in the reporting workflow.
Use only the same variant-summary fields S06 already accepts. Freeze the verdict logic and human-review criteria before revealing the historical disposition, then measure whether conflicting evidence and escalation-worthy cases are surfaced consistently without turning the screen into autonomous diagnosis.
What you provide
A case or sequence identifier and the variant-level summary your team already produces — variant counts, pathogenicity flags, clinical variant counts, conservation scores and epigenetic marker counts. No raw sequencing reads, no VCF or BAM files, no patient-identifying information changes hands.
What BivectorAI actually hands you
Bounded variant verdict
A clear research-assurance read on whether the supplied pathogenicity, burden, conservation and epigenetic summary is internally coherent or requires escalation.
Conflict and evolutionary-context finding
A separate read showing where conservation or other supplied contextual evidence supports, weakens or conflicts with the pathogenicity signal.
Human-review gate
An explicit review-required flag when the supplied evidence should not advance automatically into a report or downstream program decision.
Tamper-evident evidence package
A record ID, timestamp and tamper-evident seal tying the submitted summary to the returned verdict, limitations and review gate.
What we will never ask you for
This assessment is built around the variant-level summary your team already produces. It is not a raw-sequencing-data ingestion workflow.
We will never ask you for:
- raw sequencing reads or instrument output;
- VCF, BAM or other full genomic-coordinate files;
- patient-identifying information;
- protected health information of any kind.
The assessment works entirely from the variant-summary evidence you already track — never from raw sequencing or patient data.
How it actually runs
01 — You share your variant summary
Variant burden, pathogenicity flags, conservation and epigenetic-marker data your team already tracks per case.
02 — We validate the fit
During the scoped engagement, we confirm your data maps cleanly to the assessment and reject ambiguous submissions rather than silently guess.
03 — You receive the evidence-backed verdict and gate
A bounded verdict, variant burden class, evolutionary-pressure read and an explicit human-review flag, backed by a timestamped, sealed evidence record.
04 — You decide
The assessment informs your review board or reporting decision. It never issues a clinical diagnosis or takes an autonomous action on a case.
Strategic commercial terms
Strategic technology — direct commercial agreement only. No automated checkout applies to this strategic line; every engagement is scoped with you directly.
We do not open with an annual license. The first engagement is a fixed-scope pilot run against a batch of your own cases. If the assessment doesn't sharpen your review process, there is no reason to move into a broader commercial commitment; you keep the pilot record and stop there.
Case-batch pilot
Fixed scope
A batch of your own cases, each with a evidence-backed variant verdict — quoted per engagement, no ongoing commitment.
Private integration / NRE
On request
Environment setup, data-mapping validation, acceptance evidence and controlled deployment scope.
Annual technology license
On request
Ongoing access within the agreed field, program and deployment boundary.
Program / campaign
On request
Scoped to a single review program or campaign where the assessment generates substantial exportable decision value.
Exclusive field-of-use rights, sublicensing, source-level technical data, IP assignment, unusually broad bulk usage, and dedicated infrastructure are negotiated separately and are not included in the annual license.
Scope the S06 engagement
Request S06 Strategic Discussion →Email fallback: contact@bivectorai.com
S06 is delivered through direct strategic engagement, not a self-service public API. No automated checkout is offered for this line.